MYC and triple-negative breast carcinoma: This has been reported in MDA-MB-468 triple negative breast cancer cells following BCL3-shRNA mediated suppression but the underlying transcriptional mechanism and c-Myc promoter binding sites responsible for this regulation have not been elucidated [40].